IST:GENIL Revenue

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had revenue of 3.86B TRY in the quarter ending March 31, 2025, a decrease of -9.87%. This brings the company's revenue in the last twelve months to 14.32B, up 0.23% year-over-year. In the year 2024, Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi had annual revenue of 14.74B with 25.25% growth.

Revenue (ttm)

14.32B

Revenue Growth

+0.23%

P/S Ratio

3.52

Revenue / Employee

22.41M

Employees

619

Market Cap

50.40B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.74B	2.97B	25.25%
Dec 31, 2023	11.77B	1.13B	10.62%
Dec 31, 2022	10.64B	8.14B	325.34%
Dec 31, 2021	2.50B	351.38M	16.34%
Dec 31, 2020	2.15B	354.82M	19.77%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
MLP Saglik Hizmetleri A.S.	40.45B
Selçuk Ecza Deposu Ticaret ve Sanayi A.S.	127.65B
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.	8.03B
Deva Holding A.S.	14.70B
Tapdi Oksijen Özel Saglik ve Egitim Hizmetleri Sanayi Ticaret A.S.	2.30B
Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi	1.01B
Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi	2.09B
Turk Ilac Ve Serum Sanayi Anonim Sirketi	2.73B

Revenue Rankings